Aguilar Richard's Form 4 filing
Cano Health, Inc. (CANO) · filed Apr 6, 2023
- Accession no.
- 0000899243-23-010871
- Filed
- Apr 6, 2023
- Trade date
- Apr 5, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 derivative transactions. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aguilar RichardCIK 0001865481 | Officer (Chief Clinical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2023 | Class A Common Stock | SSaleDisposed | −4,991,807 | –F2 | – | 5,892,276 | Indirect | |
| Apr 5, 2023 | Class A Common Stock | SSaleDisposed | −4,991,807 | –F2 | – | 5,892,276 | Indirect | |
| Apr 5, 2023 | PCIH Common Units/Class B Common Stock | PPurchaseAcquired | +4,991,807 | –F4 | – | 4,991,807 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Transfer of PCIH Common Units and an equal number of shares of Class B Common Stock (the "Transferred Securities") by Aguilar Borrower Holdings LLC ("ABH") to a lender pursuant to a Stock Purchase and Repayment Agreement (the "Agreement") to pay in full the outstanding principal amount owed by the Reporting Person as guarantor to the lender under a promissory note. For such purpose, the parties agreed that the combined price for the Transferred Securities was $1.50 per share of Class B Common Stock.
Referenced by the price of 2 transactions in Table II.
- F4
In connection with the transfer described in Note (2) above, the Reporting Person obtained a right from the lender to acquire the Transferred Securities from the lender for a price equal to $3.00 per share of Class B Common Stock exercisable during the one year period following April 5, 2023, subject to the terms and conditions of the Agreement.
Referenced by the price of 1 transaction in Table II.